Selective Targeting Of Inv(16)+ AML Stem Progenitor Cells By Inhibiting HDAC8

Jing Qi(City of Hope), Ya‐Huei Kuo(City Of Hope National Medical Center), Sandeep Singh(National Metallurgical Laboratory), Chung‐I Chang(Howard Hughes Medical Institute), Qi Cai(City of Hope), Ling Li(Tumor Hospital of Guangxi Medical University), Wei‐Jan Huang(Taipei Medical University), Allen Lin(Leukemia Research Foundation), Hongjun Liu(Jiaxing University), Ravi Bhatia(University of Alabama at Birmingham), Tinisha McDonald, Hieu Vu(City of Hope)
Blood
November 15, 2013
10.1182/blood.v122.21.224.224
Cited by 0

Related Papers

PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
|Nature Genetics|2019|627
Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment
|Blood|2003|541
Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study
|Blood|2007|536
American Society of Clinical Oncology Statement: Achieving High-Quality Cancer Survivorship Care
|Journal of Clinical Oncology|2013|473
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma
|Journal of Clinical Oncology|2017|468